Do analysts rate BSX or PHG?

Boston Scientific presently has a consensus price target of $71.46, indicating a potential upside of 66.20%. Given Boston Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Boston Scientific is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Boston Scientific 2 Sell rating(s) 5 Hold rating(s) 24 Buy rating(s) 0 Strong Buy rating(s) 2.71 Koninklijke Philips 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer BSX or PHG?

In the previous week, Boston Scientific had 31 more articles in the media than Koninklijke Philips. MarketBeat recorded 32 mentions for Boston Scientific and 1 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.38 beat Boston Scientific's score of 0.56 indicating that Koninklijke Philips is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 10 Very Positive mention(s) 8 Positive mention(s) 5 Neutral mention(s) 6 Negative mention(s) 1 Very Negative mention(s) Positive Koninklijke Philips 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer PHG or EW?

Edwards Lifesciences has a consensus price target of $100.27, suggesting a potential upside of 18.61%. Given Edwards Lifesciences' stronger consensus rating and higher probable upside, analysts plainly believe Edwards Lifesciences is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Koninklijke Philips 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Edwards Lifesciences 0 Sell rating(s) 6 Hold rating(s) 17 Buy rating(s) 0 Strong Buy rating(s) 2.74

Does the media refer more to PHG or EW?

In the previous week, Edwards Lifesciences had 26 more articles in the media than Koninklijke Philips. MarketBeat recorded 27 mentions for Edwards Lifesciences and 1 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.38 beat Edwards Lifesciences' score of 0.70 indicating that Koninklijke Philips is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Koninklijke Philips 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Edwards Lifesciences 9 Very Positive mention(s) 4 Positive mention(s) 11 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend PHG or BDX?

Becton, Dickinson and Company has a consensus target price of $187.67, suggesting a potential upside of 5.52%. Given Becton, Dickinson and Company's stronger consensus rating and higher probable upside, analysts plainly believe Becton, Dickinson and Company is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Koninklijke Philips 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Becton, Dickinson and Company 1 Sell rating(s) 8 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.41

Does the media refer more to PHG or BDX?

In the previous week, Becton, Dickinson and Company had 14 more articles in the media than Koninklijke Philips. MarketBeat recorded 15 mentions for Becton, Dickinson and Company and 1 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.38 beat Becton, Dickinson and Company's score of 1.35 indicating that Koninklijke Philips is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Koninklijke Philips 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Becton, Dickinson and Company 13 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend PHG or IDXX?

IDEXX Laboratories has a consensus target price of $747.00, indicating a potential upside of 48.01%. Given IDEXX Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe IDEXX Laboratories is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Koninklijke Philips 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 IDEXX Laboratories 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.60

Does the media refer more to PHG or IDXX?

In the previous week, IDEXX Laboratories had 18 more articles in the media than Koninklijke Philips. MarketBeat recorded 19 mentions for IDEXX Laboratories and 1 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.38 beat IDEXX Laboratories' score of 1.19 indicating that Koninklijke Philips is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Koninklijke Philips 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IDEXX Laboratories 14 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend DXCM or PHG?

DexCom presently has a consensus target price of $88.71, suggesting a potential upside of 6.84%. Given DexCom's stronger consensus rating and higher possible upside, equities analysts clearly believe DexCom is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DexCom 1 Sell rating(s) 2 Hold rating(s) 21 Buy rating(s) 2 Strong Buy rating(s) 2.92 Koninklijke Philips 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher earnings & valuation, DXCM or PHG?

Koninklijke Philips has higher revenue and earnings than DexCom. Koninklijke Philips is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DexCom $4.66B 6.72 $836.30M $2.53 32.82 Koninklijke Philips $20.17B 1.20 $1.01B $1.36 18.10

Does the media favor DXCM or PHG?

In the previous week, DexCom had 11 more articles in the media than Koninklijke Philips. MarketBeat recorded 12 mentions for DexCom and 1 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.38 beat DexCom's score of 0.83 indicating that Koninklijke Philips is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DexCom 7 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Koninklijke Philips 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Koninklijke Philips (PHG) Competitors

$24.62 +0.02 (+0.06%)

Closing price 09/11/2026 03:58 PM Eastern

Extended Trading

$24.60 -0.02 (-0.08%)

As of 09/11/2026 07:30 PM Eastern

Compare

PHG vs. BSX, EW, BDX, IDXX, and DXCM

Should you buy Koninklijke Philips stock or one of its competitors? Koninklijke Philips's main competitors and comparable companies include Boston Scientific (BSX), Edwards Lifesciences (EW), Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), and DexCom (DXCM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Koninklijke Philips compare to Boston Scientific?

Boston Scientific (NYSE:BSX) and Koninklijke Philips (NYSE:PHG) are both large-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, valuation, risk and analyst recommendations.

Boston Scientific has a net margin of 17.50% compared to Koninklijke Philips' net margin of 6.30%. Boston Scientific's return on equity of 19.28% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.50%	19.28%	10.89%
Koninklijke Philips	6.30%	14.38%	5.96%

Boston Scientific has higher earnings, but lower revenue than Koninklijke Philips. Boston Scientific is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$20.07B	3.10	$2.90B	$2.47	17.41
Koninklijke Philips	$20.17B	1.20	$1.01B	$1.36	18.10

Boston Scientific has a beta of 0.57, suggesting that its stock price is 43% less volatile than the broader market. Comparatively, Koninklijke Philips has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market.

89.1% of Boston Scientific shares are held by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are held by institutional investors. 0.3% of Boston Scientific shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Boston Scientific presently has a consensus price target of $71.46, indicating a potential upside of 66.20%. Given Boston Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Boston Scientific is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	2 Sell rating(s)	5 Hold rating(s)	24 Buy rating(s)	0 Strong Buy rating(s)	2.71
Koninklijke Philips	0 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Boston Scientific had 31 more articles in the media than Koninklijke Philips. MarketBeat recorded 32 mentions for Boston Scientific and 1 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.38 beat Boston Scientific's score of 0.56 indicating that Koninklijke Philips is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	10 Very Positive mention(s)	8 Positive mention(s)	5 Neutral mention(s)	6 Negative mention(s)	1 Very Negative mention(s)	Positive
Koninklijke Philips	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Boston Scientific beats Koninklijke Philips on 12 of the 16 factors compared between the two stocks.

How does Koninklijke Philips compare to Edwards Lifesciences?

Koninklijke Philips (NYSE:PHG) and Edwards Lifesciences (NYSE:EW) are both large-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

Edwards Lifesciences has a consensus price target of $100.27, suggesting a potential upside of 18.61%. Given Edwards Lifesciences' stronger consensus rating and higher probable upside, analysts plainly believe Edwards Lifesciences is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke Philips	0 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74

Edwards Lifesciences has a net margin of 15.43% compared to Koninklijke Philips' net margin of 6.30%. Edwards Lifesciences' return on equity of 15.68% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Koninklijke Philips	6.30%	14.38%	5.96%
Edwards Lifesciences	15.43%	15.68%	12.05%

Edwards Lifesciences has lower revenue, but higher earnings than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke Philips	$20.17B	1.20	$1.01B	$1.36	18.10
Edwards Lifesciences	$6.07B	8.02	$1.07B	$1.74	48.59

13.7% of Koninklijke Philips shares are held by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are held by institutional investors. 0.3% of Edwards Lifesciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Koninklijke Philips has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market. Comparatively, Edwards Lifesciences has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market.

In the previous week, Edwards Lifesciences had 26 more articles in the media than Koninklijke Philips. MarketBeat recorded 27 mentions for Edwards Lifesciences and 1 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.38 beat Edwards Lifesciences' score of 0.70 indicating that Koninklijke Philips is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Koninklijke Philips	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Edwards Lifesciences	9 Very Positive mention(s)	4 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Edwards Lifesciences beats Koninklijke Philips on 14 of the 16 factors compared between the two stocks.

How does Koninklijke Philips compare to Becton, Dickinson and Company?

Koninklijke Philips (NYSE:PHG) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership, media sentiment and risk.

In the previous week, Becton, Dickinson and Company had 14 more articles in the media than Koninklijke Philips. MarketBeat recorded 15 mentions for Becton, Dickinson and Company and 1 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.38 beat Becton, Dickinson and Company's score of 1.35 indicating that Koninklijke Philips is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Koninklijke Philips	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Becton, Dickinson and Company	13 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Koninklijke Philips pays an annual dividend of $0.84 per share and has a dividend yield of 3.4%. Becton, Dickinson and Company pays an annual dividend of $4.20 per share and has a dividend yield of 2.4%. Koninklijke Philips pays out 61.8% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 126.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Becton, Dickinson and Company has increased its dividend for 53 consecutive years. Koninklijke Philips is clearly the better dividend stock, given its higher yield and lower payout ratio.

Koninklijke Philips has a net margin of 6.30% compared to Becton, Dickinson and Company's net margin of 4.52%. Becton, Dickinson and Company's return on equity of 14.79% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Koninklijke Philips	6.30%	14.38%	5.96%
Becton, Dickinson and Company	4.52%	14.79%	6.93%

Becton, Dickinson and Company has higher revenue and earnings than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke Philips	$20.17B	1.20	$1.01B	$1.36	18.10
Becton, Dickinson and Company	$21.84B	2.24	$1.68B	$3.32	53.57

Becton, Dickinson and Company has a consensus target price of $187.67, suggesting a potential upside of 5.52%. Given Becton, Dickinson and Company's stronger consensus rating and higher probable upside, analysts plainly believe Becton, Dickinson and Company is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke Philips	0 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Becton, Dickinson and Company	1 Sell rating(s)	8 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.41

Koninklijke Philips has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market. Comparatively, Becton, Dickinson and Company has a beta of 0.21, meaning that its share price is 79% less volatile than the broader market.

13.7% of Koninklijke Philips shares are owned by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are owned by institutional investors. 0.4% of Becton, Dickinson and Company shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Becton, Dickinson and Company beats Koninklijke Philips on 14 of the 19 factors compared between the two stocks.

How does Koninklijke Philips compare to IDEXX Laboratories?

Koninklijke Philips (NYSE:PHG) and IDEXX Laboratories (NASDAQ:IDXX) are both large-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership.

13.7% of Koninklijke Philips shares are held by institutional investors. Comparatively, 87.8% of IDEXX Laboratories shares are held by institutional investors. 0.8% of IDEXX Laboratories shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, IDEXX Laboratories had 18 more articles in the media than Koninklijke Philips. MarketBeat recorded 19 mentions for IDEXX Laboratories and 1 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.38 beat IDEXX Laboratories' score of 1.19 indicating that Koninklijke Philips is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Koninklijke Philips	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IDEXX Laboratories	14 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

IDEXX Laboratories has a net margin of 25.03% compared to Koninklijke Philips' net margin of 6.30%. IDEXX Laboratories' return on equity of 71.96% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Koninklijke Philips	6.30%	14.38%	5.96%
IDEXX Laboratories	25.03%	71.96%	33.60%

IDEXX Laboratories has lower revenue, but higher earnings than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke Philips	$20.17B	1.20	$1.01B	$1.36	18.10
IDEXX Laboratories	$4.30B	9.24	$1.06B	$14.22	35.49

Koninklijke Philips has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market. Comparatively, IDEXX Laboratories has a beta of 1.54, meaning that its stock price is 54% more volatile than the broader market.

IDEXX Laboratories has a consensus target price of $747.00, indicating a potential upside of 48.01%. Given IDEXX Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe IDEXX Laboratories is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke Philips	0 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

Summary

IDEXX Laboratories beats Koninklijke Philips on 14 of the 16 factors compared between the two stocks.

How does Koninklijke Philips compare to DexCom?

DexCom (NASDAQ:DXCM) and Koninklijke Philips (NYSE:PHG) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

DexCom has a net margin of 20.12% compared to Koninklijke Philips' net margin of 6.30%. DexCom's return on equity of 35.94% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DexCom	20.12%	35.94%	14.75%
Koninklijke Philips	6.30%	14.38%	5.96%

Koninklijke Philips has higher revenue and earnings than DexCom. Koninklijke Philips is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DexCom	$4.66B	6.72	$836.30M	$2.53	32.82
Koninklijke Philips	$20.17B	1.20	$1.01B	$1.36	18.10

DexCom has a beta of 1.42, suggesting that its stock price is 42% more volatile than the broader market. Comparatively, Koninklijke Philips has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market.

In the previous week, DexCom had 11 more articles in the media than Koninklijke Philips. MarketBeat recorded 12 mentions for DexCom and 1 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.38 beat DexCom's score of 0.83 indicating that Koninklijke Philips is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DexCom	7 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Koninklijke Philips	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

97.8% of DexCom shares are held by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are held by institutional investors. 0.3% of DexCom shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

DexCom presently has a consensus target price of $88.71, suggesting a potential upside of 6.84%. Given DexCom's stronger consensus rating and higher possible upside, equities analysts clearly believe DexCom is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DexCom	1 Sell rating(s)	2 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.92
Koninklijke Philips	0 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

DexCom beats Koninklijke Philips on 14 of the 17 factors compared between the two stocks.

Get Koninklijke Philips News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PHG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PHG vs. The Competition

Export

Metric	Koninklijke Philips	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$24.17B	$5.48B	$7.16B	$23.37B
Dividend Yield	3.42%	1.80%	2.57%	3.56%
P/E Ratio	18.14	25.09	274.94	28.72
Price / Sales	1.20	71.54	686.57	20.04
Price / Cash	7.96	32.57	76.65	34.17
Price / Book	1.91	5.97	10.33	4.74
Net Income	$1.01B	$150.75M	$3.50B	$1.07B
7 Day Performance	-4.92%	-2.83%	-3.32%	-2.00%
1 Month Performance	-10.08%	-3.73%	-0.53%	-3.20%
1 Year Performance	-12.77%	9.38%	23.51%	10.51%

Koninklijke Philips Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PHG Koninklijke Philips	3.0753 of 5 stars	$24.62 +0.1%	N/A	-12.8%	$24.17B	$20.17B	18.14	65,340	Positive News
BSX Boston Scientific	4.8824 of 5 stars	$47.85 +0.1%	$71.62 +49.7%	-58.1%	$69.27B	$20.07B	19.37	59,000	Analyst Forecast Short Interest Increase
EW Edwards Lifesciences	4.3448 of 5 stars	$90.00 +0.1%	$100.27 +11.4%	+9.1%	$51.76B	$6.07B	51.72	16,000	Trending News Analyst Forecast
BDX Becton, Dickinson and Company	3.4775 of 5 stars	$184.78 +0.0%	$187.67 +1.6%	-5.0%	$50.90B	$21.84B	55.66	72,000	Positive News
IDXX IDEXX Laboratories	4.1968 of 5 stars	$535.38 flat	$747.00 +39.5%	-21.3%	$42.18B	$4.30B	37.65	11,000	News Coverage Positive News Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:PHG) was last updated on 9/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Koninklijke Philips (PHG) Competitors

PHG vs. BSX, EW, BDX, IDXX, and DXCM

How does Koninklijke Philips compare to Boston Scientific?

Summary

How does Koninklijke Philips compare to Edwards Lifesciences?

Summary

How does Koninklijke Philips compare to Becton, Dickinson and Company?

Summary

How does Koninklijke Philips compare to IDEXX Laboratories?

Summary

How does Koninklijke Philips compare to DexCom?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHG vs. The Competition

Koninklijke Philips Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Koninklijke Philips (PHG) Competitors

PHG vs. BSX, EW, BDX, IDXX, and DXCM

How does Koninklijke Philips compare to Boston Scientific?

Is BSX or PHG more profitable?

Which has better earnings & valuation, BSX or PHG?

Which has more volatility & risk, BSX or PHG?

Do insiders and institutionals believe in BSX or PHG?

Do analysts rate BSX or PHG?

Does the media prefer BSX or PHG?

Summary

How does Koninklijke Philips compare to Edwards Lifesciences?

Do analysts prefer PHG or EW?

Is PHG or EW more profitable?

Which has higher earnings & valuation, PHG or EW?

Do institutionals & insiders hold more shares of PHG or EW?

Which has more risk & volatility, PHG or EW?

Does the media refer more to PHG or EW?

Summary

How does Koninklijke Philips compare to Becton, Dickinson and Company?

Does the media refer more to PHG or BDX?

Is PHG or BDX a better dividend stock?

Is PHG or BDX more profitable?

Which has preferable valuation and earnings, PHG or BDX?

Do analysts recommend PHG or BDX?

Which has more volatility & risk, PHG or BDX?

Do insiders and institutionals have more ownership in PHG or BDX?

Summary

How does Koninklijke Philips compare to IDEXX Laboratories?

Do institutionals & insiders have more ownership in PHG or IDXX?

Does the media refer more to PHG or IDXX?

Is PHG or IDXX more profitable?

Which has higher valuation & earnings, PHG or IDXX?

Which has more risk & volatility, PHG or IDXX?

Do analysts recommend PHG or IDXX?

Summary

How does Koninklijke Philips compare to DexCom?

Is DXCM or PHG more profitable?

Which has higher earnings & valuation, DXCM or PHG?

Which has more volatility and risk, DXCM or PHG?

Does the media favor DXCM or PHG?

Do institutionals and insiders hold more shares of DXCM or PHG?

Do analysts recommend DXCM or PHG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHG vs. The Competition

Koninklijke Philips Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools